Alyeska Investment Group
STJ

Alyeska Investment Group’s St Jude Medical STJ Stock Holding History

Alyeska Investment Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,000,000
Closed -$80.2M – 618
2016
Q4 		$80.2M Sell
1,000,000
-198,915
-17% -$15.8M 0.66% 32
2016
Q3 		$95.6M Buy
1,198,915
+52,269
+5% +$4.22M 0.88% 16
2016
Q2 		$89.4M Buy
1,146,646
+495,111
+76% +$35.3M 0.84% 18
2016
Q1 		$35.8M Buy
+651,535
New +$35.5M 0.33% 116
2014
Q2 		– Sell
-250,057
Closed -$16.4M – 486
2014
Q1 		$16.4M Buy
+250,057
New +$16.3M 0.45% 80

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alyeska Investment Group's STJ Position: Q1 2017 in Review

Alyeska Investment Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,000,000 shares — an estimated $80.2M sold.

Alyeska Investment Group first reported a position in STJ in Q1 2014 and held it in 5 quarters. The position peaked at $95.6M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Alyeska Investment Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 1,000,000 St Jude Medical shares in Q1 2017, an estimated $80.2M.
  • Alyeska Investment Group first reported a position in St Jude Medical in Q1 2014 and held it in 5 quarters.
  • Alyeska Investment Group's St Jude Medical position peaked at $95.6M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.